FMR CORP 13D and 13G filings for Arcus Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-11-12 09:50 am Sale |
2024-11-08 | 13G | Arcus Biosciences, Inc. RCUS |
FMR CORP | 4,467,557 4.886% |
-261,225![]() (-5.52%) |
Filing |
2024-02-09 08:35 am Purchase |
2024-02-08 | 13G | Arcus Biosciences, Inc. RCUS |
FMR CORP | 4,728,782 6.317% |
4,728,782![]() (New Position) |
Filing |